Eutilex.Co.,Ltd

₩959.00As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:263050Healthcare
Country South Korea
PE (Fwd) •••
TSR 8Y CAGR (33.95%)
Div yield —
ROE (102.34%)
Biological Products, Except Diagnostic Substances
Beta (5Y) 0.70
PE TTM —
TSR TTM (29.69%)
Mkt cap ₩35.32B
ROIC (22.90%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩1,126
17.42%
(30.22%)
Hold 8|9|10|12|5
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
11.00
11.92
12.75
13.01
9.86%
12.27%
22.50%
17.09%
Revenue₩B
2.027
2.136
2.220
2.344
5.98%
7.17%
11.74%
20.79%
Peers (US$26.04M)
Cap (US$)
PE
23.50M
—
Capital
TTM
5Y
10Y
Leveragex
4.349
(0.249)
(0.227)
EBIT/Intx
1.826
0.219
0.206
Own earn%
116.09
(27.07)
(58.58)
Sh yield%
29.89
37.51
36.68
Owners
Insiders/Inst%
10.67
82.04
Short interest%
4.88
SBC / revenue%
4.79
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
13–18
$1 testx
—
Incr. ROIC%
44